発見からトランスレーショナル・リサーチまで、科学を加速

“We see tremendous potential in Claude being able to streamline how we bring drugs to market. The ability to pull from various sources of clinical data and reason against them to create GxP-compliant outputs is going to help us to bring life-changing cancer therapies to patients faster while maintaining the highest standards of quality. We see tremendous potential for Claude to power AI applications across several major functions at our company.”

“AI in R&D only works through an ecosystem. Anthropic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first. Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we're building AI that powers this next chapter of R&D.”

“Broad Institute scientists pursue the most ambitious questions in biology and medicine, and we create and share tools to help empower scientists everywhere. We’ve been working closely with Manifold on the next generation of the Terra.bio platform—Terra Powered by Manifold. Among the most exciting of these upgrades are AI agents built on Claude that enable scientists to carry out tasks at an entirely new scale and efficiency and explore scientific domains in previously impossible ways.”

“Accessing 10x’s single cell and spatial analysis capabilities has traditionally required computational expertise - from writing command-line scripts to managing high-performance computing systems. Now, these same tools can respond to questions asked in plain English. Using Claude, researchers can now perform common analytical tasks—including aligning reads, generating Feature Barcode matrices, performing clustering and other secondary analysis—through a conversational interface that complements traditional computational workflows, making it faster and easier for researchers to engage directly with their data. Claude lowers the barrier to entry for new users and scales to meet the needs of large-scale analyses for advanced research teams.”

“Claude, paired with internal knowledge libraries, has become integral to Sanofi’s AI-driven transformation and is used by the majority of Sanofians on a daily basis within our internal Concierge app. We are seeing significant efficiency gains across the value-chain by optimizing our processes, while our enterprise-wide deployment has enhanced how our teams work. This collaboration with Anthropic augments human expertise to deliver life-changing medicines faster and more effectively to patients worldwide.”

“We’ve consistently been one of the first movers when it comes to document and content automation in pharma development. Our work with Anthropic and Claude has set a new standard—we’re not just automating tasks, we’re transforming how medicines get from discovery to the patients who need them.”

“Claude Code has become a powerful accelerator for us at Schrödinger. For the projects where it fits best, Claude Code allows us to turn ideas into working code in minutes instead of hours, enabling us to move up to 10x faster in some cases. As we continue to work with Claude, we are excited to see how we can further transform the way we build and customize our software.”

“At Manifold, our mission is to power faster, leaner life sciences. Building with Claude has enabled us to develop AI agents that translate questions in the semantic space of scientists to execution in the technical space of specialized datasets and tools. Together, we’re transforming how life sciences R&D will happen in the years ahead.”

“At PwC, we believe responsible AI isn’t just a technology opportunity—it’s a trust imperative. We’re proud to pair our deep sector insight with Claude’s agentic intelligence to reimagine how clinical, regulatory, and commercial teams operate. Together, we’re not just streamlining processes—we’re elevating quality, accelerating discovery, and building systems where confidence scales alongside innovation.”

“When we set out to create an AI agent that could automate bioinformatics analyses, we focused on three key factors to decide what model provider to use: top-ranking at software development, aligned with life sciences, and support for startups. We evaluated half a dozen platforms, and it became clear that Claude was the standout leader. We’re excited to continue this collaboration and bring cutting-edge AI Agents into the world of biotech research.”

“Claude has been an invaluable progress multiplier for Axiom as we build AI to predict drug toxicity. We’ve used billions of tokens in Claude Code, and use it to write many of our PRs. More recently, Claude agents with MCP servers have become core tools for our scientific work. With the right MCPs, Claude agents can directly query databases and storage services to interpret, transform, and test correlations in data, and help us identify what data and features are most useful for predicting clinical drug toxicity.”

“At FutureHouse, Claude helps power both our bioinformatics and literature analysis workflows. Claude is our model of choice for accurate figure analyses and orchestrating non-linear searches through the literature.”

“At EvolutionaryScale, we’re building next-generation AI systems to model the living world. Anthropic’s frontier models accelerate our ability to reason about complex biological data and translate it into scientific insight, helping us push the boundaries of what’s possible in life science discovery.”